UNSPSC 51183609: Insulin detemir

This classification denotes a therapeutic insulin with the molecular formula C267H402N64O76S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4FT78T86XV, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.

UNSPSC 51183609 Insulin detemir is a Commodity code representing a specific pharmaceutical product — a long-acting basal insulin — that state and local governments procure primarily through health insurance plans, Medicaid programs, and public health clinics to support diabetes management in covered populations. The code designates a branded or generic formulation of this insulin analog rather than a broader insulin family or therapeutic category, and purchasing decisions typically flow through established pharmaceutical benefit managers, state Medicaid formularies, and health plan procurement processes rather than through traditional competitive solicitation.

The source provided contains no recent state or local contract opportunities tagged to this code, and therefore offers no issuing-body, geographic, or representative-solicitation detail to support market analysis.